Novo Nordisk jumps 5% as Parvus Asset Management builds a stake to sway CEO succession amid leadership shakeup and pipeline ...

GLP-1 investors haven’t gained as much as expected from others’ losses. Since the FDA approved Wegovy, also known as ...

“After years of outsized pricing, McDonald’s core value perception appears to be increasingly challenged,” Redburn Atlantic wrote. “Rather than prompting trade-down from full-service or fast-casual, ...

The company said Tuesday it would take a $980 million write-down stemming from the deal on top of earlier impairment charges.

From an investment performance perspective, this resulted in a frustrating year for the global healthcare sector and the Company. Strong market gains in the first part of the financial year were given ...